Skip to main content

Table 1 LncRNAs deregulated in cancer through targeting the signals of metabolism

From: Emerging roles of long non-coding RNAs in tumor metabolism

LncRNA

Location

Target

Up/down

Disease

HIF1 and MYC

 H19

Chr 11p15.5

HIF1A

Up

HCC [105]

 SNHG12

/

C-MYC

Up

Breast cancer [113]

 SARCC

/

AR

Down

RCC [115]

 PCGEM1

Chr 2q32

C-MYC

Up

Prostatic cancer [111]

P53

 HULC

Chr 6p24.3

P53

Up

NPC [123]

 HOTAIR

Chr 12

P53

Up

Breast cancer [124]

 PRAL

Chr 17p13.1

P53

Down

Lung cancer [125]

PI3K/AKT/MTOR

 RP11-708H21.4

Chr 17q21

MTOR

Down

CRC [138]

 UCA1

Chr 19

MTOR/STAT3

Up

CRC [63, 122]

 linc00462

/

PI3/AKT

Down

HCC [139]

 MALAT1

Chr 11q13

PI3/AKT

Down

Cholangiocarcinoma [177]

 CASC2

Chr 10q26

PTEN

Down

CESC [7]

 HULC

Chr 6p24.3

PI3/AKT

Up

Myeloid leukemia [135]

 ANRIL

Chr 9q21

AKT

Up

NPC, glioma, CESC [33, 40]

AMP-activated protein kinase

 LINC00473

Chr 6q27

LKB1

Up

Lung cancer [143]

 NBR2

Chr 17q21

AMPK

Down

Breast cancer [34, 42]

  1. Chr chromosome, HCC hepatocellular carcinoma, NPC nasopharyngeal carcinoma, RCC renal cell carcinoma, CESC cervical cancer